Search our Current Studies
Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes
Location(s): Canton, Jacksonville - Southside, Macon
Condition: Diabetes
A Phase 1/2, Randomized, Double-blind, Placebo-controlled, 2-Part Study of the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Dose ALN-KHK in Overweight to Obese Adult Healthy Volunteers and Multiple Dose ALN-KHK in Obese Patients With Type 2 Diabetes Mellitus (T2DM)
Location(s): Jacksonville - LaVilla (Downtown), Jacksonville - Southside, Macon
Condition: Diabetes, Overweight/Obesity
Placebo Controlled, Double Blind, Randomized Cardiovascular Outcome Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With ASCVD Not Adequately Controlled Despite Maximally Tolerated Lipid Modifying Therapies
Location(s): Canton, Jacksonville (Headquarters), Jacksonville - LaVilla (Downtown), Jacksonville - Southside, Lake City, St. Augustine
Condition: Heart Disease, High Cholesterol
Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk
Location(s): Jacksonville (Headquarters), Jacksonville - Southside, Lake City, Macon, St. Augustine
Condition: Heart Disease, High Cholesterol
A Parallel-group Treatment, Phase 2, Double-blind, Three-arm Study to Assess Efficacy and Safety of Finerenone Plus Empagliflozin Compared With Either Finerenone or Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes
Location(s): Canton, Jacksonville (Headquarters), Jacksonville - LaVilla (Downtown), Jacksonville - Southside, Lake City, Macon
Condition: Diabetes, Kidney Disease
A Phase 2 Study to Evaluate the Safety and Efficacy of RTA 9 …
Location(s): Canton, Jacksonville - LaVilla (Downtown), Macon
Condition: Diabetic Peripheral Neuropathy
A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once-Daily Oral LY3502970 Compared With Placebo in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-1)
Location(s): Macon
Condition: Overweight/Obesity
This study will investigate the safety and efficacy of once daily oral treatment with orforglipron compared with placebo on body weight in adult participants with obesity or overweight and type 2 diabetes. The study will last about 77 weeks and may include up to 22 visits.
Location(s): Jacksonville (Headquarters)
Condition: Diabetes, Overweight/Obesity
Location(s): St. Augustine
Condition: Atrial Fibrillation, Heart Disease
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Participants With Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a).
Location(s): Jacksonville (Headquarters), Jacksonville - LaVilla (Downtown), St. Augustine
Condition: Heart Disease
A Phase 1b, Randomized, Double-Masked, Placebo-Controlled, M …
Location(s): Jacksonville – Florida Eye Specialist (Southpoint)
Condition: Eye Disease, Thyroid Eye Disease (TED)
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Location(s): St. Augustine
Condition: Atrial Fibrillation, Heart Disease
IMPACT2: In-Home Study with MiniMed™ 780G Pump Automated Control in Type 2 – Evaluation of the AHCL System in Adults with Insulin-requiring Type 2 Diabetes
Location(s): Canton, Jacksonville - LaVilla (Downtown), Macon
Condition: Diabetes
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT)
Location(s): Canton, Jacksonville (Headquarters), Jacksonville - LaVilla (Downtown), Lake City, Macon, Southside, St. Augustine
Condition: Heart Disease
A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL)
Location(s): St. Augustine
Condition: Heart Disease
Camera Qualification of an Additional Fundus Camera Paired W …
Location(s): Jacksonville (Headquarters)
Condition: Diabetes, Eye Disease
A Non-Interventional Study to Evaluate the Effect of Intraocular Lens (IOL) Centration and Tilt on Visual Performance in Patients Who Have Undergone Clareon® Vivity® IOL Implantation
Location(s): Jacksonville - Florida Eye Specialist (Gate)
Condition: Cataract, Eye Disease
Effects of Ziltivekimab Versus Placebo on Cardiovascular Outcomes in Participants With Established Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease and Systemic Inflammation
Location(s): Jacksonville (Headquarters)
Condition: Heart Disease, Kidney Disease
A Phase 3, Open-Label Study of Once Daily LY3502970 Compared With Insulin Glargine in Adult Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
Location(s): Macon
Condition: Diabetes, Overweight/Obesity
Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients
Location(s): Jacksonville - Florida Eye Specialist (Gate)
Condition: Ocular Hypertension, Open-Angle Glaucoma
A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat/MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction
Location(s): Jacksonville (Headquarters), St. Augustine
Condition: Heart Failure
A Phase 3, Randomized, Multi-Regional, Double-Masked, Parallel-Group Trial Evaluating the Safety and Efficacy of NCX 470 0.1% vs. Latanoprost 0.005% in Subjects With Open-Angle Glaucoma or Ocular Hypertension (Denali)
Location(s): Jacksonville - Florida Eye Specialist (Gate)
Condition: Eye Disease, Ocular Hypertension, Open-Angle Glaucoma